Search Results

240 results for fsa

3 Takeaways from Amazon’s Bid to Begin U.S. Drone Tests

Amazon’s petition to the FAA is another bold stroke by innovation czar Jeff Bezos. But don’t expect drones to take to the skies soon.

FDA’s Easing on Obesity Drugs Could Fatten Investor Wallets

Vivus and Orexigen’s diet-pill hopes are resurrected as the FDA relaxes its stance against obesity treatments.

XXII Stock Alert: Why Is 22nd Century Group Soaring Higher Today?

Agricultural biotech company 22nd Century Group is celebrating an FDA designation. As a result, XXII stock is up 40% today.

FSR Stock Alert: Fisker Delivers 100 Vehicles a Day With New Strategy

Fisker has adopted a new distribution strategy that is positive for FSR stock. But demand remains the key issue for this EV startup.

Why Logitech International SA (USA) (LOGI), Valeant Pharmaceuticals Intl Inc (VRX) and Pilgrim’s Pride Corporation (PPC) Are 3 of Today’s Worst Stocks

Logitech (LOGI), Valeant Pharmaceuticals (VRX) and Pilgrim’s Pride (PPC) used more than their fair share of red ink on Wednesday. Here’s why.

FSI Stock: The Hidden Gem of the Green Wave Revolution

Although risky and under-the-radar, if it successfully capitalizes on green trends, FSI stock could really take off in price over time.

FDA Lists 16 Dog Foods Linked to Canine Heart Disease

The U.S. Food & Drug Administration (FDA) has released a list of dog foods linked to canine heart disease in a new report.

5 Biotech Stocks With Big Catalysts on the Horizon

Announcements from, or about, these biotech stocks could greatly inflate their values … or completely deflate them.

4 Drug and Biotech Stocks Awaiting FDA Decisions in July

In the first six months of the year, the FDA grants approval to 17 new treatments. Compare Brokers….

Why Is Kaival Brands (KAVL) Stock Soaring 20% Today?

Kaival Brands was handed a disappointing ruling from the FDA, but KAVL stock is moving higher after a new appeals-court decision.

We’re Getting Closer to Legitimate Drone Stocks

The FAA has been granting drone companies approval for commercial use, but not many drone stocks are on the list.

Why Ocugen Stock Continues to Be a Great Short Opportunity

No U.S. government official has made positive comments about approving Covaxin and the Covaxin trials do not seem to meet the FDA’s preferences. OCGN stock…

Top 50 Spots to Celebrate New Year’s Eve

Priceline.com has compiled a list of the 50 top places to ring in 2013, with New York City topping the list for the second consecutive…

Inovio Pharmaceutical’s FDA Plight Makes It a Highly Risky Bet

INO stock has tumbled in the past few months. Inovio needs the FDA to bail it out by allowing the advanced trials of its vaccine…

The Same Problems Persist for Ocugen in Marketing Covaxin

OCGN stock is attempting an upward move on unrealistic expectations. There is no reason to believe it can move upward long term.

If You Want to Participate in the FSR Stock Lawsuit, Mark Your Calendars for Jan. 26

FSR stock is trending close to its lowest level ever as a class action against the EV maker gains traction.

Here’s a Top REIT to Buy for High Yield

When stocks turn up that see insider buying and are also top-ranked — like Franklin Street Properties Corp. (NYSEMKT:FSP) — investors are wise to take…

Fisker Stock Seems to Have Bottomed Out and Could Recover Long Term

Fisker is ready for production later this year and its EV looks amazing. FSR stock belongs on long-term portfolios.

6 Cheap Stocks to Buy Under $6

The dip in stocks is likely a buying opportunity as economic fundamentals remain strong, the job market remains ultra-hot and earnings growth is solid —…

Coming FDA Approvals Could Send These 3 Drug Stocks Soaring

When it comes to drug stocks, FDA approval can bring years or even decades of steady, high-margin revenue.

Buy FSI Stock Despite ‘Disappointing’ Q2 Earnings. Here’s Why.

Despite missing on revenue and earnings last quarter, FSI stock (while risky) remains a high-potential “green wave” play.

Why Is Galera Therapeutics (GRTX) Stock Down 83% Today?

Galera Therapeutics (GRTX) stock is falling hard on Thursday following a drug rejection by the FDA and plans to cut its workforce!

For Now, Amarin Stock Is a Gamble on FDA Approval

Although Amarin stock could potentially skyrocket off the pharmaceutical’s flagship drug Vascepa, approval challenges make this play incredibly risky.

Why Apple Watch Sales Could Soar With This FDA Plan in Action (AAPL)

The FDA’s Digital Health Innovation Plan could let Apple (AAPL) market its smartwatch as a medical device, lighting a fire under Apple Watch sales.

6 – 10 of 240 results